Available to sourceHuman Prescription DrugOncology & Specialty

Praxbind (idarucizumab)

50 mg/mL · Injection

By Boehringer Ingelheim Pharmaceuticals, Inc.

NDC: 0597-0197
Route: Intravenous
Therapeutic class: Antibodies, Monoclonal, Humanized [CS], Humanized Monoclonal Antibody Fragment
Marketing category: BLA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Related in Oncology & Specialty

See all →

Praxbind (idarucizumab)

Additional information

Request this medication

Related in Oncology & Specialty

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)

Verzenio (abemaciclib)